MOLECULAR PARTNERS ADS/1 (6ML0) — Defensive Interval Ratio
MOLECULAR PARTNERS ADS/1 (6ML0) has a Defensive Interval Ratio of 353 days as of December 2025. Defensive assets of €10.66 Million (cash €-, short-term investments €10.40 Million, receivables €253.00K) cover 353 days of daily cash needs of €30.21K/day. See 6ML0 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
MOLECULAR PARTNERS ADS/1 Defensive Interval Ratio (2021–2025)
This chart shows how MOLECULAR PARTNERS ADS/1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 353 days, meaning defensive assets of €10.66 Million can fund 353 days of operations without new revenue. See 6ML0 net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for MOLECULAR PARTNERS ADS/1 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for MOLECULAR PARTNERS ADS/1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see MOLECULAR PARTNERS ADS/1 (6ML0) total market value.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 353 days | €10.66 Million | €30.21K/day | €- | €10.40 Million | ▼ -2553 days |
| 2024 | 2905 days | €85.85 Million | €29.55K/day | €- | €85.56 Million | ▼ -130 days |
| 2023 | 3035 days | €119.88 Million | €39.50K/day | €- | €119.58 Million | ▼ -387 days |
| 2022 | 3422 days | €161.72 Million | €47.26K/day | €- | €161.20 Million | ▲ +2762 days |
| 2021 | 660 days | €84.71 Million | €128.40K/day | €- | €61.00 Million | — |